Is a complete FRA/4ZB research report available?

No complete published report is available for fra/4ZB (FRA/4ZB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/4ZB (FRA/4ZB)

Frankfurt Stock Exchange: FRA/4ZB · EUR

€24.6

-0.60 (-2.4%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/4ZB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.2B
Revenue (ttm)	225.5M
Net income (ttm)	-316M
EPS (ttm)	-€4.85
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 225.5M
Net income (ttm): -316M
EPS (ttm): -€4.85
Market cap: 2.2B

All FRA/4ZB indicators

Market & fundamental data

Available fields

159

Groups with data

Currency

CNY

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	DE
Employees	231
Employees Change	61%
Employees Change Percent	35.88
Enterprise value	EUR 1.8B
Exchange	Frankfurt Stock Exchange
Financial currency	CNY
First seen	2026-07-12
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-30
Market cap	EUR 2.2B
Price	EUR 24.6
Price currency	EUR
Rev Per Employee	976,119.61x
Sic	2836
Symbol	fra/4ZB
Website	https://www.dualitybiologics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-14.11%
EV/FCF	82.37x
EV/Sales	7.96x
FCF yield	1%
P/B ratio	7.58x
P/S ratio	9.93x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-24.85%
EBITDA Margin	-24.45%
FCF margin	9.29%
Gross margin	31.81%
Gross Profit	EUR 71.7M
Gross Profit Growth	-24.92%
Net Income	EUR -316M
Pretax Margin	-140.13%
Profit Margin	-140.13%
Profit Per Employee	EUR -1.4M
ROA	-9.61
ROCE	-16.2
ROE	-1,282.1
ROIC	-102.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-37.33%
FCF Growth	-35.01%
OCF Growth	-31.91%
Revenue Growth	-4.61x
Revenue Growth Q	-33.85x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.62
Assets	EUR 474M
Cash	EUR 411.6M
Current Assets	EUR 497M
Current Liabilities	EUR 136.3M
Debt	EUR 18.2M
Debt Equity	EUR 0.06
Debt FCF	EUR 0.82
Equity	EUR 295.5M
Interest Coverage	-380.3
Liabilities	EUR 178.5M
Long Term Assets	EUR -23M
Long Term Liabilities	EUR 42.2M
Net Cash	EUR 393.4M
Net Cash By Market Cap	EUR 17.57
Net Cash Growth	132.13%
Net Debt Equity	EUR -1.33
Net Debt FCF	EUR -17.65
Tangible Book Value	EUR 295M
Tangible Book Value Per Share	EUR 3.3

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.65
Net Working Capital	EUR -55M
Quick ratio	3.52
Working Capital	EUR 338.8M
Working Capital Turnover	EUR 0.55

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-714.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-37.31%
200-day SMA	31.12
50-day SMA	22.47
50-day SMA vs 200-day SMA	50under200
All Time High	58
All Time High Change	-58.28%
All Time High Date	2025-09-11
All Time Low	18.6
All Time Low Change	30.11%
All Time Low Date	2026-06-26
ATR	1.1
Ch YTD	-22.93
High	24.6
High52	58
High52 Date	2025-09-11
High52ch	-57.59%
Low	24.4
Low52	18.6
Low52 Date	2026-06-26
Low52ch	32.26%
Ma50ch	7.7%
Price vs 200-day SMA	-22.24%
RSI	53
RSI Monthly	53.91
RSI Weekly	44.75
Sharpe ratio	0.31x
Sortino ratio	0.56
Total Return	-714.45%
Tr YTD	-22.93
Tr1m	30.11%
Tr1w	-3.97%
Tr3m	-18.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -56M
Operating margin	-24.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	50,914,970%
Net Borrowing	17,710,081.6
Shares Insiders	12.78%
Shares Institutions	43.77%
Shares Qo Q	112.47%
Shares Yo Y	714.45%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 3.3M
Adjusted OCF	4,692,241
Average Volume	105.65x
Bv Per Share	3.3
CAPEX	EUR -1.4M
Ch1m	30.11
Ch1w	-3.97
Ch1y	-37.31
Ch3m	-18.24
Ch6m	-33.15
Change	-2.38%
Change From Open	0
Close	25.2
Days Gap	-2.38
Depreciation Amortization	962,612.9
Earnings Date	2026-09-18
EBIT	EUR -56M
EBITDA	EUR -55.1M
EPS	EUR -4.85
F Score	3
FCF	EUR 22.3M
FCF EV Yield	1.21x
Financing CF	220,256,581
Fiscal Year End	December
Founded	2,019
Investing CF	-232,891,438
Is Primary Listing	0
Last Report Date	2025-12-31
Ma150	29.76
Ma150ch	-18.67%
Ma20	23.27
Ma20ch	4.02%
Net CF	8,218,545
Next Earnings Date	2026-09-18
Open	24.6
P FCF Ratio	100.4
P FCF Ratio SBC	680.1
P OCF Ratio	94.48
P OCF Ratio SBC	477.1
Position In Range	100
Ppne	3,717,065.1
Price Date	2026-07-29
Ptbv Ratio	7.59
Relative Volume	0.41x
Revenue	225,483,630x
SBC By Revenue	8.43x
Share Based Comp	19,001,906
Tr6m	-33.15%
Volume	0
Z Score	9.2

FRA/4ZB (FRA/4ZB)

Coverage state: Market snapshot only — no published research

Generate the first FRA/4ZB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/4ZB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/4ZB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/4ZB

Frequently asked questions